PURE Bioscience (PURE Bioscience) EBIT per Share : $-0.03 (TTM As of Jan. 2024)

View and export this data going back to 1996. Start your Free Trial

What is PURE Bioscience EBIT per Share?

PURE Bioscience's EBIT per Share for the three months ended in Jan. 2024 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PURE Bioscience's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PURE Bioscience was 50.20% per year. The lowest was -19.60% per year. And the median was 18.95% per year.

PURE's 3-Year EBIT Growth Rate is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 7.2
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PURE Bioscience's EBIT for the three months ended in Jan. 2024 was $-0.96 Mil.

PURE Bioscience EBIT per Share Historical Data

The historical data trend for PURE Bioscience's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PURE Bioscience EBIT per Share Chart

PURE Bioscience Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

EBIT per Share

Get a 7-Day Free Trial

-0.09

-0.03

-0.04

PURE Bioscience Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBIT per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.01

PURE Bioscience EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PURE Bioscience's EBIT per Share for the fiscal year that ended in Jul. 2023 is calculated as

	EBIT per Share		(A: Jul. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.947	/	111.404
=	-0.04

PURE Bioscience's EBIT per Share for the quarter that ended in Jan. 2024 is calculated as

	EBIT per Share		(Q: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.964	/	111.856
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

PURE Bioscience (OTCPK:PURE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PURE Bioscience EBIT per Share Related Terms

Thank you for viewing the detailed overview of PURE Bioscience's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PURE Bioscience (PURE Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » PURE Bioscience Inc (OTCPK:PURE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019

Website

https://www.purebio.com

PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, products preserved with SDC and SDC as a raw material ingredient for manufacturing use.

Executives

Robert F Bartlett	director	9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Bernard Blotner	director	9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Tom Y Lee	director	1807 SAN GABRIEL BLVD., SAN GABRIEL CA 91776
David Rendall	director	9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730
Kristin Taylor	director	13500 EVENING CREEK DRIVE N, SUITE 550, SAN DIEGO CA 92128
Dale Okuno	director	35 N. ARROYO PARKWAY, SUITE 1, PASADENA CA 91103
Ivan Chen	director	1725 GILLESPIE WAY, EL CAJON CA 92020
Thomas Richard Myers	officer: Chief Operating Officer	1725 GILLESPIE WAY, EL CAJON CA 92130
Henry R. Lambert	director, officer: Chief Executive Officer	1725 GILLESPIE WAY, EL CAJON CA 92020
Elisabeth Hagen	director	1725 GILLESPIE WAY, EL CAJON CA 92020
Janet Risi Field	director	9200 SOUTH DADELAND BOULEVARD, SUITE 800, MIAMI FL 33156
Franchise Brands, Llc	10 percent owner	325 BIC DRIVE, MILFORD CT 06461
Mark Stuart Elliott	officer: Vice President, Finance	1725 GILLESPIE WAY, EL CAJON CA 92020
William Otis	director	1725 GILLESPIE WAY, EL CAJON CA 92020
David M Theno	director	1725 GILLESPIE WAY, EL CAJON CA 92020